PEN - Penumbra Inc Stock Price, Fair Value and News

201.68USD-8.32 (-3.96%)Delayed as of 08 May 2024, 02:04 pm ET

Market Summary

USD201.68-8.32

Delayedas of 08 May 2024, 02:04 pm

-3.96%

PEN Alerts

1 major insider sales recently.

PEN Stock Price

View Fullscreen

PEN RSI Chart

PEN Valuation

Market Cap

8.1B

Price/Earnings (Trailing)

87.16

Price/Sales (Trailing)

7.43

EV/EBITDA

69.56

Price/Free Cashflow

77.27

PEN Price/Sales (Trailing)

PEN Profitability

Operating Margin

65.04%

EBT Margin

7.81%

Return on Equity

7.76%

Return on Assets

5.91%

Free Cashflow Yield

1.29%

PEN Fundamentals

PEN Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

15.43%

Rev. Growth (Qtr)

-2.12%

PEN Earnings

Earnings (TTM)

93.4M

Earnings Growth (Yr)

28.5%

Earnings Growth (Qtr)

-79.71%

Breaking Down PEN Revenue

52 Week Range

199.54348.67

(Low)(High)

Last 7 days

6.9%

Last 30 days

-6.2%

Last 90 days

-20.8%

Trailing 12 Months

-32.4%

How does PEN drawdown profile look like?

PEN Financial Health

Current Ratio

6.12

PEN Investor Care

Shares Dilution (1Y)

1.34%

Diluted EPS (TTM)

2.37

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.1B	0	0	0
2023	884.6M	937.8M	995.1M	1.1B
2022	782.3M	806.4M	829.9M	847.1M
2021	592.3M	671.4M	710.5M	747.6M
2020	556.3M	527.2M	538.8M	560.4M
2019	470.7M	495.2M	522.9M	547.4M
2018	363.3M	392.3M	420.2M	444.9M
2017	278.6M	294.1M	310.8M	333.8M
2016	205.1M	227.9M	244.6M	263.3M
2015	138.3M	149.1M	167.1M	186.1M
2014	98.0M	107.2M	116.3M	125.5M
2013	0	0	0	88.8M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Penumbra Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 15, 2024	roberts johanna	sold (taxes)	-40,566	210	-193	evp, gen. counsel & secretary
Apr 01, 2024	roberts johanna	sold	-130,242	217	-600	evp, gen. counsel & secretary
Apr 01, 2024	kassing don w.	sold	-37,940	223	-170	-
Mar 15, 2024	roberts johanna	acquired	-	-	2,070	evp, gen. counsel & secretary
Mar 15, 2024	shiu lambert	sold (taxes)	-51,538	222	-232	chief accounting officer
Mar 15, 2024	roberts johanna	sold (taxes)	-41,319	222	-186	evp, gen. counsel & secretary
Mar 15, 2024	shiu lambert	acquired	-	-	1,670	chief accounting officer
Mar 15, 2024	yuen maggie	sold (taxes)	-42,874	222	-193	chief financial officer
Mar 15, 2024	yuen maggie	acquired	-	-	2,070	chief financial officer
Mar 06, 2024	elsesser adam	acquired	38,750	7.75	5,000	ceo and president

Which funds bought or sold PEN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	Candriam S.C.A.	reduced	-47.11	-4,081,640	3,609,040	0.02%
May 06, 2024	TEACHER RETIREMENT SYSTEM OF TEXAS	reduced	-18.47	-610,000	1,596,000	0.01%
May 06, 2024	Manchester Capital Management LLC	unchanged	-	-28.00	224	-%
May 06, 2024	NEW YORK LIFE INVESTMENT MANAGEMENT LLC	reduced	-1.93	-142,340	953,871	0.01%
May 06, 2024	TEXAS PERMANENT SCHOOL FUND CORP	added	1.31	-847,798	7,538,800	0.06%
May 06, 2024	HighTower Advisors, LLC	added	7.77	-32,000	473,000	-%
May 06, 2024	Parallel Advisors, LLC	added	9.65	-778	27,898	-%
May 06, 2024	SG Americas Securities, LLC	sold off	-100	-358,000	-	-%
May 06, 2024	DiNuzzo Private Wealth, Inc.	unchanged	-	-28.00	224	-%
May 06, 2024	Envestnet Portfolio Solutions, Inc.	new	-	241,481	241,481	-%

Are Funds Buying or Selling PEN?

Are funds buying PEN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PEN

No. of Funds

PEN Alerts

1 major insider sales recently.

Unveiling Penumbra Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	price t rowe associates inc /md/	8.0%	3,105,828	SC 13G
Feb 13, 2024	vanguard group inc	9.48%	3,658,102	SC 13G/A
Feb 09, 2024	capital research global investors	6.9%	2,677,789	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 24, 2024	blackrock inc.	10.4%	4,000,277	SC 13G/A
Feb 13, 2023	capital research global investors	6.1%	2,321,719	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 09, 2023	vanguard group inc	9.13%	3,467,792	SC 13G/A
Jan 23, 2023	blackrock inc.	11.6%	4,422,738	SC 13G/A
Oct 07, 2022	blackrock inc.	10.3%	3,904,542	SC 13G/A

Recent SEC filings of Penumbra Inc

View All Filings

Date Filed	Form Type	Document
May 07, 2024	10-Q	Quarterly Report
May 07, 2024	8-K	Current Report
Apr 24, 2024	ARS	ARS
Apr 24, 2024	DEF 14A	DEF 14A
Apr 24, 2024	DEFA14A	DEFA14A
Apr 17, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 01, 2024	144	Notice of Insider Sale Intent
Mar 21, 2024	8-K	Current Report

Peers (Alternatives to Penumbra Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	184.5B	40.3B	-4.60%	-4.35%	32.81	4.58	-2.84%	-3.08%
BDX	68.5B	19.7B	-3.65%	-5.69%	51.42	3.48	4.82%	-17.56%
ALGN	21.6B	3.9B	-9.77%	-6.38%	46.66	5.51	5.72%	46.72%
BAX	18.4B	14.9B	-15.25%	-20.81%	6.95	1.24	2.98%	207.68%
MID-CAP
ATR	9.9B	3.5B	5.58%	23.16%	31.71	2.8	6.16%	35.06%
HSIC	9.1B	12.5B	-1.81%	-10.76%	23.5	0.73	-0.61%	-18.83%
BIO	8.2B	2.7B	-13.87%	-26.12%	-12.81	3.06	-4.68%	82.43%
XRAY	5.9B	3.9B	-12.53%	-31.61%	-62.76	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	-0.62%	22.51%	-215.76	8.88	30.82%	65.57%
PDCO	2.3B	6.6B	-0.84%	-0.80%	12.05	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-6.97%	-19.30%	-1.87	0.4	7.94%	-1661.78%
ANIK	420.5M	166.7M	10.85%	9.31%	-5.09	2.52	6.67%	-456.34%
ANGO	245.9M	324.0M	-12.80%	-31.58%	-1.28	0.76	-3.19%	-337.41%
APYX	48.8M	52.3M	-6.00%	-59.48%	-2.61	0.93	17.61%	19.28%
AEMD	3.4M	3.7M	-25.71%	271.43%	-0.27	0.89	5.77%	8.23%

Penumbra Inc News

Latest updates

Penumbra Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-2.1%	279	285	271	261	241	221	214	208	204	204	190	184	169	167	151	105	137	145	140	134	128
Cost Of Revenue	-0.2%	98.00	98.00	93.00	95.00	90.00	83.00	78.00	74.00	76.00	79.00	70.00	66.00	58.00	73.00	60.00	40.00	49.00	47.00	44.00	40.00	45.00
Gross Profit	-3.1%	181	187	178	167	151	138	135	134	127	125	120	119	111	94.00	91.00	65.00	88.00	98.00	96.00	94.00	84.00
Operating Expenses	11.2%	169	152	165	149	143	134	130	134	131	166	111	108	98.00	96.00	111	83.00	87.00	88.00	83.00	81.00	73.00
S&GA Expenses	11.1%	144	130	126	127	123	116	109	115	111	114	94.00	91.00	80.00	77.00	76.00	60.00	74.00	75.00	69.00	68.00	61.00
R&D Expenses	-	-	-	-	22.00	20.00	-	21.00	20.00	21.00	-	17.00	18.00	18.00	-	35.00	23.00	13.00	-	14.00	13.00	12.00
EBITDA Margin	2.9%	0.10*	0.10*	0.08*	0.07*	0.05*	0.03*	-0.02*	-0.02*	-0.01*	0.01*	0.06*	0.02*	-	-	-	-	-	-	-	-	-
Income Taxes	122.6%	4.00	-16.06	4.00	1.00	0.00	3.00	5.00	3.00	-5.18	-16.32	-0.25	2.00	2.00	-3.14	-9.85	-4.13	-1.63	2.00	2.00	-2.73	1.00
Earnings Before Taxes	-61.7%	15.00	38.00	13.00	20.00	9.00	7.00	3.00	-1.17	-5.10	-40.95	8.00	10.00	12.00	-0.51	-19.73	-17.03	-0.75	12.00	13.00	14.00	12.00
EBT Margin	3.8%	0.08*	0.08*	0.05*	0.04*	0.02*	0.00*	-0.05*	-0.05*	-0.04*	-0.01*	0.04*	0.00*	-	-	-	-	-	-	-	-	-
Net Income	-79.7%	11.00	54.00	9.00	19.00	9.00	4.00	-2.27	-3.69	0.00	-24.63	9.00	9.00	12.00	4.00	-8.81	-11.96	1.00	10.00	11.00	17.00	11.00
Net Income Margin	-0.8%	0.09*	0.09*	0.04*	0.03*	0.01*	0.00*	-0.04*	-0.02*	-0.01*	0.01*	0.05*	0.02*	-	-	-	-	-	-	-	-	-
Free Cashflow	-0.4%	32.00	33.00	28.00	13.00	9.00	-2.22	-19.26	-44.01	-9.47	-17.36	31.00	-6.60	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	1.5%	1,580	1,556	1,468	1,433	1,395	1,371	1,322	1,328	1,302	1,244	973	841	823	810	780	664	666	614	585	569	558
Current Assets	2.1%	935	915	868	828	786	756	724	718	690	681	668	635	618	590	576	454	463	451	435	423	410
Cash Equivalents	33.2%	223	167	101	114	95.00	70.00	55.00	58.00	68.00	59.00	66.00	56.00	70.00	80.00	134	72.00	73.00	112	77.00	96.00	68.00
Inventory	2.7%	398	388	374	359	344	334	320	296	274	264	258	245	220	192	183	166	153	140	133	122	116
Net PPE	4.2%	76.00	73.00	66.00	66.00	65.00	65.00	64.00	63.00	60.00	59.00	57.00	50.00	48.00	65.00	62.00	59.00	52.00	46.00	38.00	35.00	35.00
Goodwill	-0.1%	166	166	166	166	166	166	165	166	166	166	159	8.00	8.00	8.00	8.00	8.00	8.00	7.00	8.00	8.00	8.00
Liabilities	-0.3%	376	377	364	366	371	372	348	358	342	290	289	190	185	191	157	176	180	147	131	132	93.00
Current Liabilities	1.1%	153	151	145	144	146	145	138	146	130	123	116	112	106	108	78.00	88.00	91.00	86.00	70.00	69.00	66.00
Shareholder's Equity	2.1%	1,204	1,179	1,104	1,067	1,024	999	974	970	959	954	685	650	638	620	623	488	486	467	454	437	422
Retained Earnings	8.2%	146	135	81.00	71.00	52.00	44.00	40.00	42.00	46.00	46.00	71.00	52.00	41.00	37.00	46.00	58.00	58.00	48.00	36.00	20.00	9.00
Additional Paid-In Capital	1.5%	1,062	1,047	1,031	1,001	979	963	947	938	919	911	621	603	598	585	581	436	431	423	419	420	415
Shares Outstanding	-100.0%	-	39.00	38.00	38.00	38.00	38.00	38.00	38.00	38.00	38.00	37.00	36.00	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-6.20	-4.62	-3.71	-2.69	-1.63	-0.82	-0.28	-0.39	0.00	-0.07	0.00
Float	-	-	-	-	12,700	-	-	-	4,500	-	-	-	-	-	-	6,000	-	-	-	5,100	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	5.6%	38,295	36,261	30,844	17,099	13,129	1,337	-12,909	-39,575	-4,514	-9,270	36,450	-3,310	-14,368	-2,083	-3,550	-21,689	-5,920	4,767	22,050	1,903	-2,068
Share Based Compensation	25.7%	13,569	10,791	14,136	12,823	12,766	9,997	9,702	8,786	8,893	41,662	7,903	9,803	6,395	8,055	6,238	5,559	5,689	5,014	6,241	5,135	5,095
Cashflow From Investing	-24.3%	18,384	24,280	-44,396	-6,671	10,711	8,633	9,786	20,660	15,711	-1,339	-49,831	26,345	3,090	-10,226	-49,416	-54,544	10,037	-43,734	14,281	-15,113	31,855
Cashflow From Financing	-113.4%	-794	5,921	212	8,694	1,376	5,735	-603	9,131	-2,641	2,961	-2,684	3,173	-2,614	2,457	-1,651	138,461	-4,350	-502	-1,439	-5,308	-1,710

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

PEN Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue	$ 1,058,522	$ 847,133	$ 747,590
Cost of revenue	375,879	311,926	272,208
Gross profit	682,643	535,207	475,382
Operating expenses:
Research and development	84,423	79,407	104,552
Sales, general and administrative	506,454	449,718	378,331
Acquired in-process research and development	18,215	0	0
Total operating expenses	609,092	529,125	482,883
Income (loss) from operations	73,551	6,082	(7,501)
Interest and other income (expense), net	6,099	(2,190)	(3,001)
Income (loss) before income taxes	79,650	3,892	(10,502)
(Benefit from) provision for income taxes	(11,304)	5,894	(13,125)
Consolidated net income (loss)	90,954	(2,002)	2,623
Net loss attributable to non-controlling interest	0	0	(2,661)
Net income (loss) attributable to Penumbra, Inc.	$ 90,954	$ (2,002)	$ 5,284
Net income (loss) attributable to Penumbra, Inc. per share:
Net income (loss) attributable to Penumbra, Inc. per share: Basic (in dollars per share)	$ 2.37	$ (0.05)	$ 0.14
Net income (loss) attributable to Penumbra, Inc. per share: Diluted (in dollars per share)	$ 2.32	$ (0.05)	$ 0.14
Weighted average shares outstanding:
Weighted average shares outstanding: Basic (in shares)	38,401,171	37,841,874	36,764,290
Weighted average shares outstanding: Diluted (in shares)	39,216,564	37,841,874	37,881,180

PEN Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 167,486	$ 69,858
Marketable investments	121,701	118,172
Accounts receivable, net of allowance for credit losses of $3,169 and $862 at December 31, 2023 and 2022, respectively	201,768	203,384
Inventories	388,023	334,006
Prepaid expenses and other current assets	36,424	30,279
Total current assets	915,402	755,699
Property and equipment, net	72,691	65,015
Operating lease right-of-use assets	188,756	192,636
Finance lease right-of-use assets	31,092	33,323
Intangible assets, net	71,056	81,161
Goodwill	166,270	166,046
Deferred taxes	85,158	64,213
Other non-current assets	25,880	12,793
Total assets	1,556,305	1,370,886
Current liabilities:
Accounts payable	27,155	26,679
Accrued liabilities	110,555	106,300
Current operating lease liabilities	11,203	10,033
Current finance lease liabilities	2,231	1,920
Total current liabilities	151,144	144,932
Non-current operating lease liabilities	197,229	198,955
Non-current finance lease liabilities	23,680	24,865
Other non-current liabilities	5,308	3,276
Total liabilities	377,361	372,028
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value per share - 5,000,000 shares authorized, none issued and outstanding at December 31, 2023 and December 31, 2022	0	0
Common stock, $0.001 par value per share - 300,000,000 shares authorized, 38,681,549 issued and outstanding at December 31, 2023; 300,000,000 shares authorized, 38,107,977 issued and outstanding at December 31, 2022	39	38
Additional paid-in capital	1,047,198	963,040
Accumulated other comprehensive loss	(3,151)	(8,124)
Retained earnings	134,858	43,904
Total stockholders’ equity	1,178,944	998,858
Total liabilities and stockholders’ equity	$ 1,556,305	$ 1,370,886

About Penumbra Inc

Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System, Lightning, and CAT RX brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and POD (Penumbra Occlusion Device) brand, as well as immersive 3D computer-based technology platform under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

CEO	Mr. Adam Elsesser
WEBSITE	penumbrainc.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	3900

Penumbra Inc Frequently Asked Questions

What is the ticker symbol for Penumbra Inc? What does PEN stand for in stocks?

PEN is the stock ticker symbol of Penumbra Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Penumbra Inc (PEN)?

As of Tue May 07 2024, market cap of Penumbra Inc is 8.14 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PEN stock?

You can check PEN's fair value in chart for subscribers.

What is the fair value of PEN stock?

You can check PEN's fair value in chart for subscribers. The fair value of Penumbra Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Penumbra Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PEN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Penumbra Inc a good stock to buy?

The fair value guage provides a quick view whether PEN is over valued or under valued. Whether Penumbra Inc is cheap or expensive depends on the assumptions which impact Penumbra Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PEN.

What is Penumbra Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, PEN's PE ratio (Price to Earnings) is 87.16 and Price to Sales (PS) ratio is 7.43. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PEN PE ratio will change depending on the future growth rate expectations of investors.